BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Peretz A, Paritsky M, Dinisman-Zavulunov E, Pastukh N, Glyatman T, On A. Susceptibility of Helicobacter pylori to Levofloxacin and Rifampicin in Israel. Microb Drug Resist 2015;21:448-51. [PMID: 25793253 DOI: 10.1089/mdr.2014.0250] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Boltin D, Schmilovitz-weiss  H, Gingold-belfer R, Leibovitzh  H, Snir Y, Perets  T, Dickman R, Levi Z, Niv Y. Temporal Trends in <b><i>Helicobacter pylori</i></b> Eradication Success in a Test-and-Treat Population. Digestion 2018;98:169-74. [DOI: 10.1159/000488448] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
2 Khoury J, Geffen Y, Shaul R, Sholy H, Chowers Y, Saadi T. Secondary antibiotic resistance of Helicobacter pylori isolates in Israeli children and adults. Journal of Global Antimicrobial Resistance 2017;10:182-5. [DOI: 10.1016/j.jgar.2017.05.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
3 Yeganeh M, Paritsky M, On A, Azrad M, Roshrosh H, Moalem R, Peretz A. Characteristics of Antibiotic Resistance of Helicobacter pylori Among Adult Arab and Jewish Populations in Northern Israel. Microb Drug Resist 2019;25:103-7. [PMID: 30129819 DOI: 10.1089/mdr.2018.0148] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Pastukh N, Peretz A, Brodsky D, Isakovich N, Azrad M, On A. Antimicrobial susceptibility of Helicobacter pylori strains isolated from children in Israel. Journal of Global Antimicrobial Resistance 2018;12:175-8. [DOI: 10.1016/j.jgar.2017.10.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
5 Miftahussurur M, Waskito LA, Syam AF, Nusi IA, Siregar G, Richardo M, Bakry AF, Rezkitha YAA, Wibawa IDN, Yamaoka Y. Alternative eradication regimens for Helicobacter pylori infection in Indonesian regions with high metronidazole and levofloxacin resistance. Infect Drug Resist. 2019;12:345-358. [PMID: 30774400 DOI: 10.2147/idr.s187063] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
6 Binyamin D, Pastukh N, On A, Paritsky M, Peretz A. Phenotypic and genotypic correlation as expressed in Helicobacter pylori resistance to clarithromycin and fluoroquinolones. Gut Pathog 2017;9. [DOI: 10.1186/s13099-017-0198-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Domanovich-Asor T, Motro Y, Khalfin B, Craddock HA, Peretz A, Moran-Gilad J. Genomic Analysis of Antimicrobial Resistance Genotype-to-Phenotype Agreement in Helicobacter pylori. Microorganisms 2020;9:E2. [PMID: 33374988 DOI: 10.3390/microorganisms9010002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]